A carregar...

Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis

BACKGROUND:  New first-line drug regimens for treatment of tuberculosis (TB) are in clinical trials: emergence of resistance is a key concern. Because population-level data on resistance cannot be collected in advance, epidemiological models are important tools for understanding the drivers and dyna...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Shrestha, Sourya, Knight, Gwenan M., Fofana, Mariam, Cohen, Ted, White, Richard G., Cobelens, Frank, Dowdy, David W.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4281792/
https://ncbi.nlm.nih.gov/pubmed/25734143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofu073
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!